1Aoun E, Shamseddine A. Transfusion-associated GVHD: 10 years, experience at the American University of Beirut-Medical Center[ J]. Transfusion,2003,43 (12) : 1672-1682.
4Anwar M, Bhatti FA. Transfusion associated graft versus host disease [J]. J Ayub Med Coil Abottabad. ,2003,15(3) :56-86.
5Wagner FF. Transfusion-associated graft-versus-host disease:risk due to homozygous HLA haplotypes [J]. Transfusion, 1995,35 : 284-291.
6Hutchinson K, Kopko PM. Early diagnosis and successful treatment of a patient with transfusion-asscciated GVHD with autologous peripheral blood progenitor cell transplantation[J]. Transfusion ,2002,42(12) :1567-1572.
7Gupta A, Bansal D. Transfusion-associated graft-versus-host disease [J]. Indian Pedlatr,2004,41 (12) :1260-1264.
8Moriyama S, Kurihara K. Evaluation of absorbed dose-distribution in the X-ray or gamma-irradiator for blood products [ J ]. Yakugaku Zasshi, 2001,121 (4) : 283 -288
6Ware LB, Mathay MA. The acute respiratory distress syndrome. N Engl J Meel, 2000,342(3) :1334-1339.
7Ringwald J, Schroth M, Faschingbauer F, et al. Intrauterine use of hyperconcentrated platelet concentrates collected with Trima Accel in a case of neonatal alloimmune thrombocytopenia [ J ]. Transfusion, 2007,47 ( 8 ) : 1488-1493.
8Ware LB, Matthay MA. The acute respiratory distress syndrome[J]. N Engl J Med,2000,342(3):1334-1349.
